BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 24004119)

  • 1. Results of the two incidence screenings in the National Lung Screening Trial.
    Aberle DR; DeMello S; Berg CD; Black WC; Brewer B; Church TR; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gatsonis CA; Gierada DS; Jain A; Jones GC; Mahon I; Marcus PM; Rathmell JM; Sicks J;
    N Engl J Med; 2013 Sep; 369(10):920-31. PubMed ID: 24004119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
    Yoo H; Kim KH; Singh R; Digumarthy SR; Kalra MK
    JAMA Netw Open; 2020 Sep; 3(9):e2017135. PubMed ID: 32970157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
    Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of initial low-dose computed tomographic screening for lung cancer.
    ; Church TR; Black WC; Aberle DR; Berg CD; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gierada DS; Jones GC; Mahon I; Marcus PM; Sicks JD; Jain A; Baum S
    N Engl J Med; 2013 May; 368(21):1980-91. PubMed ID: 23697514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced lung-cancer mortality with low-dose computed tomographic screening.
    ; Aberle DR; Adams AM; Berg CD; Black WC; Clapp JD; Fagerstrom RM; Gareen IF; Gatsonis C; Marcus PM; Sicks JD
    N Engl J Med; 2011 Aug; 365(5):395-409. PubMed ID: 21714641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
    Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
    Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.
    Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A
    Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers.
    Diederich S; Thomas M; Semik M; Lenzen H; Roos N; Weber A; Heindel W; Wormanns D
    Eur Radiol; 2004 Apr; 14(4):691-702. PubMed ID: 14727146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probability of cancer in pulmonary nodules detected on first screening CT.
    McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
    N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds.
    Henschke CI; Yip R; Smith JP; Wolf AS; Flores RM; Liang M; Salvatore MM; Liu Y; Xu DM; Yankelevitz DF;
    AJR Am J Roentgenol; 2016 Dec; 207(6):1176-1184. PubMed ID: 27726410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
    Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
    Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for lung cancer.
    Midthun DE
    Clin Chest Med; 2011 Dec; 32(4):659-68. PubMed ID: 22054878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the Risk of Malignancy Among Detected Lung Nodules in the National Lung Screening Trial.
    Hassannezhad R; Vahed N
    J Am Coll Radiol; 2018 Nov; 15(11):1529-1535. PubMed ID: 30145120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis?
    Starnes SL; Reed MF; Meyer CA; Shipley RT; Jazieh AR; Pina EM; Redmond K; Huffman LC; Pandalai PK; Howington JA
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):688-93. PubMed ID: 20933243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
    Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
    Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of low-dose computed tomography screening for lung cancer over five years.
    Veronesi G; Maisonneuve P; Spaggiari L; Rampinelli C; Pardolesi A; Bertolotti R; Filippi N; Bellomi M
    J Thorac Oncol; 2014 Jul; 9(7):935-939. PubMed ID: 24922008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.